Kirjojen hintavertailu – 12 903 725 kirjaa ja 27 kauppaa

Kirjailija

Frank Yeomans

Kirjat ja teokset yhdessä paikassa: 2 kirjaa, julkaisuja vuosilta 2000–2018, suosituimpiin kuuluu Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

2 kirjaa

Kirjojen julkaisuvuodet: 2000–2018.

Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America

Borderline Personality Disorder, An Issue of Psychiatric Clinics of North America

Frank Yeomans; Kenneth Levy

Elsevier - Health Sciences Division
2018
sidottu
This issue of Psychiatric Clinics of North America, edited by Drs. Frank Yeomans and Kenneth Levy, will offer a comprehensive review of key topics of importance in the study of Borderline Personality Disorder. The series is led by our Consulting Editor, Dr. Harsh Trivedi of Sheppard Pratt Health System. This issue will explore the following topics: Conceptual models, Diagnosis and assessment, Differential diagnosis, Community and Clinical Epidemiology, Comorbidity, Longitudinal Course, Neuroscience and social cognition, Attachment, Psychotherapy and medication treatment research, Psychotherapy with children and adolescents, and Family and patient perspectives, among others.
Borderline Patients: Extending The Limits Of Treatability

Borderline Patients: Extending The Limits Of Treatability

Ann Appelbaum; Frank Yeomans; Harold Koenigsberg; Michael Stone; Otto Kernberg

Basic Books
2000
sidottu
Borderline conditions are a growing presence in the treatment room, yet they are uncommonly resistant to treatment. Dr. Kernberg and his colleagues have already articulated the modality they call Transference-Focused Psychotherapy. Now, in an unusually textured elabouration, they confront the complications that limit treatability,co-existing psychopathologies, early trauma issociation, problems endemic to the therapeutic situation (attachment disturbances, erotic transferences),and bring new rounds of clinical ammunition to meet those challenges.